Abstract
Aim Antimicrobial resistance is an emerging global health challenge, driven largely by the overuse of antimicrobial drugs. However, the extent of mouthwash-induced antimicrobial resistance remains poorly understood. This systematic review aimed to assess the influence of commonly used mouthwashes on antimicrobial resistance, focusing on resistance genes, microbial alterations, and cross-resistance to antibiotics.
Methods PubMed, Scopus, Web of Science, and grey literature, including Google Scholar, were searched for studies evaluating mouthwash-induced antimicrobial resistance. The search strategy included terms related to ‘oral microbiome', ‘mouthwash' and ‘antimicrobial resistance', with Boolean operators tailored to each database. Risk of bias was assessed using In Vitro Critical Appraisal Tool for in vitro studies and the Modified Joanna Briggs Institute for ex vivo and in vivo studies, respectively.
Results Twelve studies were analysed, comprising seven in vitro, four ex vivo and one in vivo study. A total of 91 patients and 213 bacterial isolates were assessed across various mouthwashes, including chlorhexidine digluconate, cetylpyridinium chloride, hydrogen peroxide and others. Due to heterogeneous outcomes, a meta-analysis was not conducted. The findings consistently revealed increased minimum inhibitory concentrations of oral bacteria and the presence of resistance genes, highlighting a potential rise in antimicrobial resistance.
Conclusion This systematic review indicates a possible association between mouthwash use and resistance-related changes in the oral microbiome; however, the limited and heterogeneous evidence base warrants cautious interpretation. Further, longitudinal research is needed to elucidate the underlying mechanisms and inform evidence-based guidelines for mouthwash use.
Key points
-
This review consolidates evidence that frequent or prolonged use of antiseptic mouthwashes, especially chlorhexidine, can foster resistance traits in oral bacteria marked by increased MICs and resistance gene amplification.
-
The findings support a more judicious, individualised approach to mouthwash prescribing, discouraging routine, unsupervised use, and reinforcing the importance of antimicrobial stewardship in dental practice.
-
Highlights the need to revisit current guidelines on antiseptic mouthwash use and advocates for clearer regulatory policies addressing over-the-counter availability and labelling in the context of antimicrobial resistance.
-
Stresses the critical need for high-quality, long-term human studies to validate in vitro findings and to explore mechanisms of resistance and cross-resistance in clinical settings.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
All data generated or analysed during this systematic review are included in this published article and its supplementary materials. The extracted data tables, search strategies, and risk of bias assessments are available upon request from the corresponding author. No new datasets were generated for this study.
References
World Health Organization. Antimicrobial resistance fact sheet. 2023. Available at https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed 1 November 2025).
O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016. Available at https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed 1 November 2025).
Laxminarayan R. The overlooked pandemic of antimicrobial resistance. Lancet 2022; 399: 606–607.
Lu J, Guo J. Disinfection spreads antimicrobial resistance. Science 2021; 371: 474.
Merchel Piovesan Pereira B, Tagkopoulos I. Benzalkonium chlorides: uses, regulatory status, and microbial resistance. Appl Environ Microbiol 2019; DOI: 10.1128/AEM.00377-19.
Mao X, Auer D L, Buchalla W et al. Cetylpyridinium chloride: mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistance. Antimicrob Agents Chemother 2020; DOI: 10.1128/AAC.00576-20.
Cieplik F, Jakubovics N S, Buchalla W, Maisch T, Hellwig E, Al-Ahmad A. Resistance toward chlorhexidine in oral bacteria – is there cause for concern? Front Microbiol 2019; 10: 587.
Wand M E, Bock L J, Bonney L C, Sutton J M. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother 2016; DOI: 10.1128/AAC.01162-16.
Laumen,J G E, van Dijck C et al. Sub-Inhibitory concentrations of chlorhexidine induce resistance to chlorhexidine and decrease antibiotic susceptibility in Neisseria gonorrhoeae. Front Microbiol 2021; 12: 776909.
Roberts A P, Mullany P. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther 2010; 8: 1441–1450.
Jiang S, Zeng J, Zhou X, Li Y. Drug resistance and gene transfer mechanisms in respiratory/oral bacteria. J Dent Res 2018; 97: 1092–1099.
Salam M A, Al-Amin M Y, Salam M T et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel) 2023; 11: 1946.
Higgins J P T, Thomas J, Chandler J et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. 2024. Available at www.training.cochrane.org/handbook (accessed 1 November 2025).
Page M J, McKenzie J E, Bossuyt P M et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; DOI: 10.1136/bmj.n71.
Moola S, Munn Z, Sears K et al. In Aromatics E, Lockwood C, Porritt K, Pilla B, Jordan Z (eds) JBI Manual for Evidence Synthesis. Joanna Briggs Institute, 2020.
De Vries R, Whaley P. In Vitro Critical Appraisal Tool (IV-CAT): tool development protocol. 2018. Available at https://zenodo.org/records/1493498 (accessed 1 November 2025).
Bartsch S, Kohnert E, Kreutz C et al. Chlorhexidine digluconate mouthwash alters the oral microbial composition and affects the prevalence of antimicrobial resistance genes. Front Microbiol 2024; 15: 1429692.
Tansirichaiya S, Reynolds L J, Cristarella G, Wong L C, Rosendahl K, Roberts A P. Reduced susceptibility to antiseptics is conferred by heterologous housekeeping genes. Microb Drug Resist 2018; 24: 105–112.
Verspecht T, Rodriguez Herrero E, Khodaparast L et al. Development of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro. Sci Rep 2019; 9: 8326.
Wigand J, Tansirichaiya S, Winje E, Al-Haroni M. Functional screening of a human saliva metagenomic DNA reveal novel resistance genes against sodium hypochlorite and chlorhexidine. BMC Oral Health 2021; 21: 632.
Früh R, Anderson A, Cieplik F et al. Antibiotic resistance of selected bacteria after treatment of the supragingival biofilm with subinhibitory chlorhexidine concentrations. Antibiotics (Basel) 2022; 11: 1420.
Auer D L, Mao X, Anderson A C et al. Phenotypic adaptation to antiseptics and effects on biofilm formation capacity and antibiotic resistance in clinical isolates of early colonizers in dental plaque. Antibiotics (Basel) 2022; 11: 688.
Kulik E M, Waltimo T, Weiger R et al. Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro. Clin Oral Investig 2015; 19: 1547–1553.
Huang S, Huang J, Du J et al. The LiaSR two-component system regulates resistance to chlorhexidine in Streptococcus mutans. Microorganisms 2024; 12: 468.
Arpag O F, Duran N, Açikgül F C, Türkmen M. Comparison of minimum inhibitory concentrations of Hypericum perforatum L essential oils, 0.2% chlorhexidine and 10% povidone-iodine over Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. J Essent Oil Bearing Plants 2020; 23: 1192–1205.
Do Amaral G C L S, Hassan M A, Sloniak M C, Pannuti C M, Romito G A, Villar C C. Effects of antimicrobial mouthwashes on the human oral microbiome: Systematic review of controlled clinical trials. Int J Dent Hyg 2023; 21: 128–140.
Mao X, Hiergeist A, Auer D L et al. Ecological effects of daily antiseptic treatment on microbial composition of saliva-grown microcosm biofilms and selection of resistant phenotypes. Front Microbiol 2022; 13: 934525.
Suzuki Y, Ohsumi T, Isono T et al. Effects of a sub-minimum inhibitory concentration of chlorhexidine gluconate on the development of in vitro multi-species biofilms. Biofouling 2020; 36: 146–158.
Michaelis C, Grohmann E. Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics (Basel) 2023; 12: 328.
Şener B, Kiliç M. Herbal extracts used in dental disorders. Biomed J Sci Tech Res 2019; 19: 14107–14111.
Amsalu A, Sapula S A, de Barros Lopes M et al. Efflux pump-driven antibiotic and biocide cross-resistance in Pseudomonas aeruginosa isolated from different ecological niches: a case study in the development of multidrug resistance in environmental hotspots. Microorganisms 2020; 8: 1647.
Abbood H M, Hijazi K, Gould I M. Chlorhexidine resistance or cross-resistance, that is the question. Antibiotics 2023; 12: 798.
Buxser S. Has resistance to chlorhexidine increased among clinically-relevant bacteria? A systematic review of time course and subpopulation data. PLos One 2021; DOI: 10.1371/journal.pone.0256336.
DeRiso A J 2nd, Ladowski J S, Dillon T A, Justice J W, Peterson A C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996; 109: 1556–1561.
D'Journo X B, Falcoz P-E, Alifano M et al. Oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate in lung cancer surgery: a randomized clinical trial. Intensive Care Med 2018; 44: 578–587.
Lambert R J. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000. J Appl Microbiol 2004; 97: 699–711.
Joshipura K J, Muñoz-Torres F J, Morou-Bermudez E, Patel R P. Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. Nitric Oxide 2017; 71: 14–20.
Author information
Authors and Affiliations
Contributions
ASH: conceptualisation, data screening and extraction, manuscript drafting. NDG: supervision, risk of bias assessment, critical review. SK: data screening and extraction., data interpretation. NA: risk of bias assessment, data interpretation. SAA: data screening and extraction, manuscript editing. MA: data screening and extraction, manuscript writing.
Corresponding author
Ethics declarations
The authors declare no conflicts of interest related to this study. Ethical approval and consent was not required for this study, as it is a systematic review of previously published data.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hashmi, A., Gupta, N., Khan, S. et al. Evaluation of mouthwash-induced antimicrobial resistance in the oral microbiome: a systematic review. Br Dent J (2025). https://doi.org/10.1038/s41415-025-9012-9
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41415-025-9012-9


